-
Columbus surpasses growth expectations
Columbus surpassed its organic growth expectations in 2023, delivering growth of 11%, and 15% adjusted for currency and acquisition. The growth is expected to continue. The Company has set new goals for the future, aiming to continuously grow the top line by 10% annually and improve profitability to an EBITDA margin of 15% by the end of 2026. -
-
Strong Q3 Interim Report, new ambitious growth targets for 2024-2026 and new focus on Life Science
In the third quarter of 2023, Columbus once again delivered impressive organic top-line growth of 15% (excluding acquisitions and currency), and the increase in operating profit (EBITDA) was as much as 28%. Columbus has created a solid foundation for the upcoming strategy period – New Heights – which in particular will focus on boosting profitability with an EBITDA margin of 15% by the end of 2026. Columbus expects 10% compounded annual growth in 2024 – 2026. -
-
-
Columbus Q1 2023: Higher efficiency boosts operating profit by 33%
Columbus experienced good momentum in the first quarter of the year. Revenue increased by 7% (12% in local currencies) and operating profit increased by 33% in Q1 2023. The optimization of the delivery organization is now really taking effect with a boost in efficiency to 67% against 62% in Q1 2022.